HRT Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

HRT Financial’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,548	Closed	-$238K	–	2644
2024 Q2	$238K	Buy	+1,548	New	+$232K	﹤0.01%	1594
2023 Q4	–	Sell	-3,687	Closed	-$539K	–	2539
2023 Q3	$539K	Buy	3,687 +800	+28%	+$122K	0.01%	1374
2023 Q2	$442K	Buy	+2,887	New	+$450K	﹤0.01%	1427
2021 Q2	–	Sell	-34,177	Closed	-$5.49M	–	3044
2021 Q1	$5.49M	Buy	+34,177	New	+$5.85M	0.06%	272
2020 Q4	–	Sell	-49,283	Closed	-$7.75M	–	2034
2020 Q3	$7.75M	Buy	+49,283	New	+$8.06M	0.23%	74
2016 Q3	–	Sell	-7,288	Closed	-$651K	–	136
2016 Q2	$651K	Sell	7,288 -20,033	-73%	-$1.84M	0.4%	39
2016 Q1	$2.39M	Buy	+27,321	New	+$2.41M	2.5%	8

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

HRT Financial's FBT Position: Q3 2024 in Review

HRT Financial sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2024, closing a stake of 1,548 shares — an estimated $238K sold.

HRT Financial first reported a position in FBT in Q1 2016 and held it in 7 quarters. The position peaked at $7.75M in Q3 2020. 257 funds tracked by Wall St. Rank hold FBT as of Q3 2024.

HRT Financial reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2024 after selling out during the quarter.
HRT Financial sold 1,548 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2024, an estimated $238K.
HRT Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2016 and held it in 7 quarters.
HRT Financial's First Trust NYSE Arca Biotechnology Index Fund position peaked at $7.75M in Q3 2020.
257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.